Risk Factors and Management of Osteoporosis Post-Transplant

Bone and mineral disorders are common after organ transplantation. Osteoporosis post transplantation is associated with increased morbidity and mortality. Pathogenesis of bone disorders in this particular sub set of the population is complicated by multiple co-existing factors like preexisting bone...

Full description

Bibliographic Details
Main Authors: Karthik Kovvuru, Swetha Rani Kanduri, Pradeep Vaitla, Rachana Marathi, Shiva Gosi, Desiree F. Garcia Anton, Franco H. Cabeza Rivera, Vishnu Garla
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/56/6/302
_version_ 1797706576491970560
author Karthik Kovvuru
Swetha Rani Kanduri
Pradeep Vaitla
Rachana Marathi
Shiva Gosi
Desiree F. Garcia Anton
Franco H. Cabeza Rivera
Vishnu Garla
author_facet Karthik Kovvuru
Swetha Rani Kanduri
Pradeep Vaitla
Rachana Marathi
Shiva Gosi
Desiree F. Garcia Anton
Franco H. Cabeza Rivera
Vishnu Garla
author_sort Karthik Kovvuru
collection DOAJ
description Bone and mineral disorders are common after organ transplantation. Osteoporosis post transplantation is associated with increased morbidity and mortality. Pathogenesis of bone disorders in this particular sub set of the population is complicated by multiple co-existing factors like preexisting bone disease, Vitamin D deficiency and parathyroid dysfunction. Risk factors include post-transplant immobilization, steroid usage, diabetes mellitus, low body mass index, older age, female sex, smoking, alcohol consumption and a sedentary lifestyle. Immunosuppressive medications post-transplant have a negative impact on outcomes, and further aggravate osteoporotic risk. Management is complex and challenging due to the sub-optimal sensitivity and specificity of non-invasive diagnostic tests, and the underutilization of bone biopsy. In this review, we summarize the prevalence, pathophysiology, diagnostic tests and management of osteoporosis in solid organ and hematopoietic stem cell transplant recipients.
first_indexed 2024-03-12T05:53:22Z
format Article
id doaj.art-4b7ce809291e44309d6c37e5e2685a31
institution Directory Open Access Journal
issn 1010-660X
language English
last_indexed 2024-03-12T05:53:22Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-4b7ce809291e44309d6c37e5e2685a312023-09-03T04:53:09ZengMDPI AGMedicina1010-660X2020-06-015630230210.3390/medicina56060302Risk Factors and Management of Osteoporosis Post-TransplantKarthik Kovvuru0Swetha Rani Kanduri1Pradeep Vaitla2Rachana Marathi3Shiva Gosi4Desiree F. Garcia Anton5Franco H. Cabeza Rivera6Vishnu Garla7Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39156, USADivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39156, USADivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39156, USADivision of Hospital Medicine, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39156, USADepartment of Hospital Medicine, Banner Thunderbird Medical Center, Glenadale, AZ 85306, USADivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39156, USADivision of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39156, USADepartment of Internal Medicine and Mississippi Center for Clinical and Translational Research, University of Mississippi Medical Center, Jackson, MS 39156, USABone and mineral disorders are common after organ transplantation. Osteoporosis post transplantation is associated with increased morbidity and mortality. Pathogenesis of bone disorders in this particular sub set of the population is complicated by multiple co-existing factors like preexisting bone disease, Vitamin D deficiency and parathyroid dysfunction. Risk factors include post-transplant immobilization, steroid usage, diabetes mellitus, low body mass index, older age, female sex, smoking, alcohol consumption and a sedentary lifestyle. Immunosuppressive medications post-transplant have a negative impact on outcomes, and further aggravate osteoporotic risk. Management is complex and challenging due to the sub-optimal sensitivity and specificity of non-invasive diagnostic tests, and the underutilization of bone biopsy. In this review, we summarize the prevalence, pathophysiology, diagnostic tests and management of osteoporosis in solid organ and hematopoietic stem cell transplant recipients.https://www.mdpi.com/1010-660X/56/6/302osteoporosisorgan transplantationbone diseasekidney transplantliver transplant
spellingShingle Karthik Kovvuru
Swetha Rani Kanduri
Pradeep Vaitla
Rachana Marathi
Shiva Gosi
Desiree F. Garcia Anton
Franco H. Cabeza Rivera
Vishnu Garla
Risk Factors and Management of Osteoporosis Post-Transplant
Medicina
osteoporosis
organ transplantation
bone disease
kidney transplant
liver transplant
title Risk Factors and Management of Osteoporosis Post-Transplant
title_full Risk Factors and Management of Osteoporosis Post-Transplant
title_fullStr Risk Factors and Management of Osteoporosis Post-Transplant
title_full_unstemmed Risk Factors and Management of Osteoporosis Post-Transplant
title_short Risk Factors and Management of Osteoporosis Post-Transplant
title_sort risk factors and management of osteoporosis post transplant
topic osteoporosis
organ transplantation
bone disease
kidney transplant
liver transplant
url https://www.mdpi.com/1010-660X/56/6/302
work_keys_str_mv AT karthikkovvuru riskfactorsandmanagementofosteoporosisposttransplant
AT swetharanikanduri riskfactorsandmanagementofosteoporosisposttransplant
AT pradeepvaitla riskfactorsandmanagementofosteoporosisposttransplant
AT rachanamarathi riskfactorsandmanagementofosteoporosisposttransplant
AT shivagosi riskfactorsandmanagementofosteoporosisposttransplant
AT desireefgarciaanton riskfactorsandmanagementofosteoporosisposttransplant
AT francohcabezarivera riskfactorsandmanagementofosteoporosisposttransplant
AT vishnugarla riskfactorsandmanagementofosteoporosisposttransplant